PT - JOURNAL ARTICLE AU - Samuel J Westall AU - Ram Prakash Narayanan AU - Simon Watmough AU - Greg Irving AU - Niall Furlong AU - Sid McNulty AU - Sumudu Bujawansa AU - Kevin Hardy TI - The individualisation of glycaemic targets in response to patient characteristics in type 2 diabetes: a scoping review AID - 10.7861/clinmed.2021-0764 DP - 2022 May 01 TA - Clinical Medicine PG - 257--265 VI - 22 IP - 3 4099 - http://www.rcpjournals.org/content/22/3/257.short 4100 - http://www.rcpjournals.org/content/22/3/257.full SO - Clin Med2022 May 01; 22 AB - Background Evidence and guidelines increasingly support an individualised approach to care for people with type 2 diabetes and individualisation of glycaemic targets in response to patient factors.Methods We undertook a scoping review of the literature for evidence of factors impacting upon glycated haemoglobin target individualisation in adults with type 2 diabetes. Data were analysed thematically with the themes inductively derived from article review.Findings Evidence suggests that presence of cardiovascular disease, hypoglycaemia unawareness, severe hypoglycaemia, limited life expectancy, advanced age, long diabetes duration, frailty, cognitive impairment, disability, extensive comorbidity, diabetes distress and patient preference should inform the setting of glycaemic targets.Conclusion The management of people with diabetes is complex. In clinical practice, many patients will have a variety of factors that should be considered when personalising their care. Approaches to personalised care and glycaemic treatment targets should be undertaken as part of a shared decision-making process between physician and patient. Use of electronic records might enable greater efficiency and more widespread use of personalised care plans for people with diabetes.